Código QR (código de barras bidimensional)

Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004–2024)

Abstract Background Ganirelix, a third-generation GnRH antagonist, is widely used in assisted reproductive technology (ART) for rapid pituitary suppression to prevent premature luteinizing hormone (LH) surges. Despite its extensive clinical use, real-world evidence on its safety in large populations...

Fuld beskrivelse

Na minha lista:
Principais autores: Yang Yang, Zhiwei Cui, Xiaoshan Feng, Fan Zou, Xiaoling Wu
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-04-01
Serier:BMC Pharmacology and Toxicology
Fag:
Ganirelix
Adverse drug events
Pharmacovigilance
Real-world evidence
FAERS
JADER
Online adgang:https://doi.org/10.1186/s40360-025-00920-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker